Support Programs
for Pharmacists

Join the Specialty Medication Revolution

Wholly owned by the Association québécoise des pharmaciens propriétaires, Accessa manages a new generation of patient support programs (PSPs).

We focus on the accessibility and proximity of the community pharmacy network, providing comprehensive and personalized care to patients with severe, rare, or chronic illnesses.

By joining Accessa, you become part of a deeply human project that places patients and their treatment outcomes at the center of your actions.

A Secure and Standardized Solution Helping Your Practice Evolve

As your practice expands, your workload becomes more demanding. Accessa is here to support your pharmaceutical practice as it evolves.

We offer practical solutions to organize operations, standardize processes, and maintain regulatory compliance—all while optimizing care for patients with complex conditions.

Additionally, we take on part of the administrative management of the programs, allowing you to focus on clinical interventions.

Diversify your service offerings and improve the continuity of patient care by enrolling in Accessa’s PSPs today.

How Does It Work?

In Accessa’s PSPs, you and your team are the patient’s primary point of contact.

Working in collaboration with the treating physician, you provide comprehensive patient care without fragmenting their pharmacological and health care records. You also oversee their therapeutic journey.

Throughout the care process, you and your team document interventions in the Curo™ platform to capture treatment progress. You also assist patients with reimbursement requests so they can focus on their health.

Accessa’s team supports you every step of the way, simplifying your tasks through training, personalized optimization services, and more.

The Curo™ platform also guides you through the entire process of personalized patient care, providing both clinical and administrative support.

5 adalimumab (Humira™) biosimilars:

  • Hyrimoz™
  • Hulio™
  • Simlandi™
  • Amgevita™
  • Hadlima™

2 etanercept (Enbrel™) biosimilars :

  • Erelzi™
  • Brenzys™

3 Pegfilgrastim (Neulasta™) biosimilars:

  • Fulphila™
  • Lapelga™
  • Ziextenzo™

2 filgrastim (Neupogen™) biosimilars:

  • Grastofil™
  • Nypozi™

2 teriflunomide (Aubagio™) generics:

  • Mantra-Teriflunomide™
  • Apo Teriflunoide™

1 dimethyl fumarate (Tecfidera™) generic:

  • Apo-Dimethyl Fumarate™

Oral Iron Chelators

1 deferasirox (Janedu™, Exjade™) generic:

  • Apo-Deferasirox™

1 apremilast (Otezla™) generic:

  • Sandoz-Apremilast™

1 eltrombopag (Revolade™) generic:

  • Apo-Eltrombopag™

1 fulvestrant (Faslodex™) biosimilar:

  • Fulvestrant™

1 palbociclib (Ibrance™) biosimilar

  • Taro-Palbociclib
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.